Case Study - Enabling the Trinity Biotech acquisition of Fiomi Diagnostics

413 views

Published on

Sagentia was asked by Trinity Biotech to conduct the technical due diligence on Fiomi Diagnostics’ cardiac point-of-care diagnostic system prior to its potential acquisition.
http://www.sagentia.com/new-technologies

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
413
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Case Study - Enabling the Trinity Biotech acquisition of Fiomi Diagnostics

  1. 1. The approach Sagentia was asked by Trinity Biotech to conduct the technical due diligence on Fiomi Diagnostics’ cardiac point- of-care diagnostic system prior to its potential acquisition. We evaluated the instrument, consumable and manufacturing processes to comment on robustness; suitability for high volume manufacture; and to identify potential technical hurdles associated with the development of an acceptable product.. The end result Trinity Biotech was better informed about Fiomi Diagnostics and able to make the acquisition for $13.1m with a solid understanding of the company’s current and future technical position. Technical due diligence enables acquisition and provides access to $900m market

×